Neylan John F. (CIK 0001640447)

Latest company ownership

ELTX - Elicio Therapeutics, Inc.

Role: Officer

Shares held

100,000

Last filed at

Mar 4, 2022

Confidence Score

50.0

2025Q4

Confidence Score History

2021Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Dec 20, 2021	Dec 21, 2021	Elicio Therapeutics, Inc.	Officer	Sell	50.0	-358	-1.01%	✓	$938
Nov 18, 2021	Nov 22, 2021	Elicio Therapeutics, Inc.	Officer	Sell	50.0	-374	-1.04%	✓	$1.5K
Oct 18, 2021	Oct 20, 2021	Elicio Therapeutics, Inc.	Officer	Sell	50.0	-373	-1.03%	✓	$3.2K
Sep 20, 2021	Sep 21, 2021	Elicio Therapeutics, Inc.	Officer	Sell	50.0	-376	-1.03%	✓	$3.8K
Aug 18, 2021	Aug 19, 2021	Elicio Therapeutics, Inc.	Officer	Sell	50.0	-381	-1.03%	✓	$3.4K
Jul 21, 2021	Jul 22, 2021	Elicio Therapeutics, Inc.	Officer	Sell	52.5	-365	-0.98%	✓	$4K
Jun 18, 2021	Jun 21, 2021	Elicio Therapeutics, Inc.	Officer	Sell	52.5	-366	-0.97%	✓	$4.8K
May 18, 2021	May 19, 2021	Elicio Therapeutics, Inc.	Officer	Sell	52.5	-363	-0.95%	✓	$5K
Apr 19, 2021	Apr 20, 2021	Elicio Therapeutics, Inc.	Officer	Sell	52.5	-381	-0.99%	✓	$5.2K
Mar 17, 2021	Mar 19, 2021	Elicio Therapeutics, Inc.	Officer	Sell	47.5	-442	-1.14%	✗	$8.5K